Pakwebearn

Subscribe to pakwebearn

Powered by us.groups.yahoo.com

search

Orexigen Therapeutics Inc. said Monday that in three large late-stage studies its obesity-drug candidate Contrave met its main goals and also surpassed a Food and Drug Administration requirement for effectiveness. The San Diego-based company said it plans to seek FDA approval for Contrave in early 2010.

Sponsers

Monitor link Promote Your Blog Buzzer Hut | Promote Your Blog Monitor link Entertainment blogs Top Blogs Bloglisting.net - The
 internets fastest growing blog directory

Valid XHTML 1.0 Transitional

affiliate best program

Blogging

Search Engine Optimization SEO

Submit Your Site To The Web's Top 50 Search Engines for Free! Submit Your Site To The Web's Top 50 Search Engines for Free! Submit Your Site To The Web's Top 50 Search Engines for Free! Submit Your Site To The Web's Top 50 Search Engines for Free! Submit Your Site To The Web's Top 50 Search Engines for Free! Submit Your Site To The Web's Top 50 Search Engines for Free! Submit Your Site To The Web's Top 50 Search Engines for Free!